Molina loses Medicaid contract in Virginia
It’s the second recent Medicaid state loss for Molina, despite executives expressing confidence about the insurer’s ability to retain contracts.
Uncategorized
Abbott leader on the ‘hype’ and ‘reality’ of pulsed field ablation
Christopher Piorkowski, chief medical officer for the electrophysiology business, talks about the high expectations for the new atrial fibrillation treatment.
Abbott leader on the ‘hype’ and ‘reality’ of pulsed field ablation Read More »
Change Healthcare cyberattack having ‘far-reaching’ effects on providers
Providers said the outage at the UnitedHealth-owned technology company has affected billing, eligibility checks, prior authorization requests and prescription fulfillment.
Change Healthcare cyberattack having ‘far-reaching’ effects on providers Read More »
Cleveland Clinic posts $911M net income in 2023 on investment, volume growth
The health system is the latest to report a financial turnaround compared to 2022, which analysts called the worst operational year on record for nonprofit hospitals.
Cleveland Clinic posts $911M net income in 2023 on investment, volume growth Read More »
Boston Scientific gains FDA nod for drug-coated coronary balloon
BTIG analyst Marie Thibault said physicians could rapidly adopt the first-of-its-kind device.
Boston Scientific gains FDA nod for drug-coated coronary balloon Read More »
Medtronic asks ITC to stop sales, imports of Axonics devices
The complaint is the latest move in a long-running patent fight between the two companies regarding neuromodulation devices.
Medtronic asks ITC to stop sales, imports of Axonics devices Read More »
Ironwood Nabs Phase III Win, Still Sees Stock Nosedive
Despite Ironwood Pharmaceuticals’ apraglutide getting positive late-stage study results in treating short bowel syndrome with intestinal failure, the stock plummeted nearly 40% on Thursday.
Ironwood Nabs Phase III Win, Still Sees Stock Nosedive Read More »
Walgreens’ VillageMD to exit Illinois
The primary care chain will shutter its remaining clinics in the state on April 19, marking the latest closures as Walgreens cuts costs.
Rare Disease Day Reminds Biopharma of Opportunities, Challenges
The annual observance highlights how far the industry has come and serves as a wake-up call for how far it must still go to meet the needs of patients with rare diseases.
Rare Disease Day Reminds Biopharma of Opportunities, Challenges Read More »
Boston Scientific Receives FDA Approval for the AGENT™ Drug-Coated Balloon
Boston Scientific Corporation (NYSE: BSX) today announced it has received U.S. Food and Drug Administration (FDA) approval for the AGENT™ Drug-Coated Balloon (DCB).
Boston Scientific Receives FDA Approval for the AGENT™ Drug-Coated Balloon Read More »